Antioxidant action of 3-mercapto-5H-1,2,4-triazino[5,6-b]indole-5-acetic acid, an efficient aldose reductase inhibitor, in a 1,1′-diphenyl-2-picrylhydrazyl assay and in the cellular system of isolated erythrocytes exposed to tert-butyl hydroperoxide

References

• Hotta N. New approaches for treatment in diabetes: aldose reductase inhibitors. Biomed Pharmacother 1995;5:244–50.
   Google Scholar
• Yabe-Nishimura C. Aldose reductase in glucose toxicity: a potential target for the prevention of diabetic complications. Pharmacol Rev 1998;50:21–33.
   PubMed Web of Science ®Google Scholar
• Del Corso A, Cappiello M, Mura U. From a dull enzyme to something else: facts and perspectives regarding aldose reductase. Curr Med Chem 2008;15:1452–61. doi: 10.2174/092986708784638870
   PubMed Web of Science ®Google Scholar
• Oates PJ. Aldose reductase, still a compelling factor for diabetic neuropathy. Curr Drug Targets 2008;9:14–36. doi: 10.2174/138945008783431781
   PubMed Web of Science ®Google Scholar
• Palsamy P, Bidasee KR, Ayaki M, Augusteyn RC, Chan JY, Shinohara T. Methylglyoxal induces endoplasmic reticulum stress and DNA demethylation in the Keap 1 promoter of human lens epithelial cells and age-related cataracts. Free Radic Biol Med 2014;72:134–48. doi: 10.1016/j.freeradbiomed.2014.04.010
   PubMed Web of Science ®Google Scholar
• Liu H, Cao MM, Wang Y, Li LC, Zhu LB, Xie GY, et al.Endoplasmic reticulum stress is involved in the connection between inflammation and autophagy in type 2 diabetes. Gen Comp Endocrinol 2015;210:124–9. doi: 10.1016/j.ygcen.2014.09.006
   PubMed Web of Science ®Google Scholar
• Chistiakov DA, Sobenin IA, Orekhov AN, Bobryshev YV. Role of endoplasmic reticulum stress in atherosclerosis and diabetic macrovascular complications. Biomed Res Int 2014;2014:610140.
   PubMedGoogle Scholar
• O'Brien PD, Hinder LM, Sakowski SA, Feldman EL. ER Stress in diabetic peripheral neuropathy: a new therapeutic target. Antioxid Redox Signal 2014;21(4):621–33. doi: 10.1089/ars.2013.5807
   PubMed Web of Science ®Google Scholar
• Fiorentino TV, Prioletta A, Zuo P, Folli F. Hyperglycemia-induced oxidative stress and its role in diabetes mellitus related cardiovascular diseases. Curr Pharm Des 2013;19(32):5695–703. doi: 10.2174/1381612811319320005
   PubMed Web of Science ®Google Scholar
• Bhuyan KC, Bhuyan DK. Molecular mechanism of cataractogenesis: III. Toxic metabolites of oxygen as initiators of lipid peroxidation and cataract. Curr Eye Res 1984;3:67–81. doi: 10.3109/02713688408997188
   PubMed Web of Science ®Google Scholar
• Altomare E, Vendemiale G, Grattagliano I, Angelini P, Micelli-Ferrari T, Cardia L. Human diabetic cataract: role of lipid peroxidation. Diabetes Metab 1995;21:173–9.
   PubMed Web of Science ®Google Scholar
• Altomare E, Grattagliano I, Vendemaile G, Micelli-Ferrari T, Signorile A, Cardia L. Oxidative protein damage in human diabetic eye: evidence of a retinal participation. Eur J Clin Invest 1997;27:141–7. doi: 10.1046/j.1365-2362.1997.780629.x
   PubMed Web of Science ®Google Scholar
• Baynes JW, Thorpe SR. Perspectives in diabetes: role of oxidative stress in diabetic complication – a new perspective on an old paradigm. Diabetes 1999;48:1–9. doi: 10.2337/diabetes.48.1.1
   PubMed Web of Science ®Google Scholar
• Kubo E, Miyoshi N, Fukuda M, Akagi Y. Cataract formation through the polyol pathway is associated with free radical production. Exp Eye Res 1999;68:457–64. doi: 10.1006/exer.1998.0624
   PubMed Web of Science ®Google Scholar
• Kyselova Z, Stefek M, Bauer V. Pharmacological prevention of diabetic cataract. J Diabetes Complications 2004;18(2):129–40. doi: 10.1016/S1056-8727(03)00009-6
   PubMed Web of Science ®Google Scholar
• Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes 2005;54:1615–25. doi: 10.2337/diabetes.54.6.1615
   PubMed Web of Science ®Google Scholar
• Kyselova Z, Garcia SJ, Gajdosikova A, Gajdosik A, Stefek M. Temporal relationship between lens protein oxidation and cataract development in streptozotocin-induced diabetic rats. Physiol Res 2005;54(1):49–56.
   PubMed Web of Science ®Google Scholar
• Stefek M, Gajdosikova A, Gajdosik A, Kyselova Z, Djoubissie P-O, Krizanova L. Glyco-oxidative mechanisms in glucose toxicity: biochemical changes of matrix collagen in diabetic rats. Biologia 2005;60(Suppl. 17):109–12.
   Google Scholar
• Obrosova IG. Increased sorbitol pathway activity generates oxidative stress in tissue sites for diabetic complications. Antioxid Redox Signal 2005;7:1543–52. doi: 10.1089/ars.2005.7.1543
   PubMed Web of Science ®Google Scholar
• Monnier VM, Mustata GT, Biemel KL, Reihl O, Lederer MO, Zhenyu D, et al.Cross-linking of the extracellular matrix by the Maillard reaction in aging and diabetes: an update on ‘a puzzle nearing resolution’. Ann N Y Acad Sci 2005;1043:533–44. doi: 10.1196/annals.1333.061
   PubMed Web of Science ®Google Scholar
• Ohta Y, Yamasaki T, Niwa T, Majima Y, Ishiguro I. Preventive effect of topical vitamin E-containing liposome instillation on the progression of galactose cataract. Comparison between 5-week- and 12-week-old rats fed a 25% galactose diet. Exp Eye Res 1999;68:747–55. doi: 10.1006/exer.1998.0672
   PubMed Web of Science ®Google Scholar
• Agardh E, Hultberg B, Agardh C. Effects of inhibition of glycation and oxidative stress on the development of cataract and retinal vessel abnormalities in diabetic rats. Curr Eye Res 2000;21:543–9. doi: 10.1076/0271-3683(200007)2111-ZFT543
   PubMed Web of Science ®Google Scholar
• Packer L, Kraemer K, Rimbach G. Molecular aspects of lipoic acid in the prevention of diabetes complications. Nutrition 2001;17:888–95. doi: 10.1016/S0899-9007(01)00658-X
   PubMed Web of Science ®Google Scholar
• Stefek M, Gajdosik A, Tribulova N, Navarova J, Volkovova K, Weismann P, et al.The pyridoindole antioxidant stobadine attenuates albuminuria, enzymuria, kidney lipid peroxidation and matrix collagen cross-linking in streptozotocin-induced diabetic rats. Methods Find Exp Clin Pharmacol 2002;24(9):565–71.
   PubMedGoogle Scholar
• Ulusu NN, Sahilli M, Avci A, Canbolat O, Ozansoy G, Ari N, et al.Pentose phosphate pathway, glutathione-dependent enzymes and antioxidant defense during oxidative stress in diabetic rodent brain and peripheral organs: effect of stobadine and vitamin E. Neurochem Res 2003;28(6):815–23. doi: 10.1023/A:1023202805255
   PubMed Web of Science ®Google Scholar
• Kyselova Z, Gajdosik A, Gajdosikova A, Ulicna O, Mihalova D, Karasu C, et al.Effect of the pyridoindole antioxidant stobadine on development of experimental diabetic cataract and on lens protein oxidation in rats: comparison with vitamin E and BHT. Mol Vis 2005;11:56–65.
   PubMed Web of Science ®Google Scholar
• Juranek I, Horakova L, Rackova L, Stefek M. Antioxidants in treating pathologies involving oxidative damage: an update on medicinal chemistry and biological activity of stobadine and related pyridoindoles. Curr Med Chem 2010;17(6):552–70. doi: 10.2174/092986710790416317
   PubMed Web of Science ®Google Scholar
• Aldini G, Vistoli G, Stefek M, Chondrogianni N, Grune T, Sereikaite J, et al.Molecular strategies to prevent, inhibit, and degrade advanced glycoxidation and advanced lipoxidation end products. Free Radic Res 2013;47(Suppl. 1 SI):93–137. doi: 10.3109/10715762.2013.792926
   PubMed Web of Science ®Google Scholar
• Costantino L, Rastelli G, Gamberini MC, Barlocco D. Pharmacological approaches to the treatment of diabetic complications. Expert Opin Ther Pat 2000;10:1245–62. doi: 10.1517/13543776.10.8.1245
   Web of Science ®Google Scholar
• Miyamoto S. Recent advances in aldose reductase inhibitors: potential agents for the treatment of diabetic complications. Expert Opin Ther Pat 2002;12:621–31. doi: 10.1517/13543776.12.5.621
   Web of Science ®Google Scholar
• Alexiou P, Pegklidou K, Chatzopoulou M, Nicolaou I, Demopoulos VJ. Aldose reductase enzyme and its implication to major health problems of the 21(st) century. Curr Med Chem 2009;16:734–52. doi: 10.2174/092986709787458362
   PubMed Web of Science ®Google Scholar
• Srivastava SK, Ramana KV, Bhatnagar A. Role of aldose reductase and oxidative damage in diabetes and the consequent potential for therapeutic options. Endocr Rev 2005;26:380–92. doi: 10.1210/er.2004-0028
   PubMed Web of Science ®Google Scholar
• Chatzopoulou M, Alexiou P, Kotsampasakou E, Demopoulos VJ. Novel aldose reductase inhibitors: a patent survey (2006–present). Expert Opin Ther Pat 2012;11:1303–23. doi: 10.1517/13543776.2012.726615
   Web of Science ®Google Scholar
• Maccari R, Ottana R. Targeting aldose reductase for the treatment of diabetes complications and inflammatory diseases: new insights and future directions. J Med Chem 2015;58(5):2047–67. doi: 10.1021/jm500907a
   PubMed Web of Science ®Google Scholar
• Coudert P, Albuisson E, Boire JY, Duroux E, Bastide P, Couquelet J. Synthesis of pyridazine acetic acid derivatives possessing aldose reductase inhibitory activity and antioxidant properties. Eur J Med Chem 1994;29:471–7. doi: 10.1016/0223-5234(94)90074-4
   Web of Science ®Google Scholar
• Costantino L, Rastelli G, Gamberini MC, Vinson JA, Bose P, Iannone A, et al.1-Benzopyran-4-one antioxidants and aldose reductase inhibitors. J Med Chem 1999;42:1881–93. doi: 10.1021/jm980441h
   PubMed Web of Science ®Google Scholar
• La Motta C, Sartini S, Mugnaini L, Simorini F, Taliani S, Salerno S, et al.Pyrido[1,2-a] pyrimidin-4-one derivatives as a novel class of selective aldose reductase inhibitors exhibiting antioxidant activity. J Med Chem 2007;50:4917–27. doi: 10.1021/jm070398a
   PubMed Web of Science ®Google Scholar
• Stefek M, Snirc V, Djoubissie P-O, Majekova M, Demopoulos V, Rackova L, et al.Carboxymethylated pyridoindole antioxidants as aldose reductase inhibitors: synthesis, activity, partitioning, and molecular modelling. Bioorg Med Chem 2008;16:4908–20. doi: 10.1016/j.bmc.2008.03.039
   PubMed Web of Science ®Google Scholar
• Stefek M, Soltesova Prnova M, Majekova M, Rechlin C, Heine A, Klebe G. Identification of novel aldose reductase inhibitors based on carboxymethylated mercapto-triazino-indole scaffold. J Med Chem 2015;58(6):2649–57. doi: 10.1021/jm5015814
   PubMed Web of Science ®Google Scholar
• Winterbourn CC. Oxidative reactions of hemoglobin. Methods Enzymol 1990;186:265–72. doi: 10.1016/0076-6879(90)86118-F
   PubMed Web of Science ®Google Scholar
• Mihaljevic B, Katusin-Razem B, Razem B. The reevaluation of the ferric thiocyanate assay for lipid hydroperoxides with special considerations of the mechanistic aspects of the response. Free Radic Biol Med 1996;21(1):53–63. doi: 10.1016/0891-5849(95)02224-4
   PubMed Web of Science ®Google Scholar
• Blois MS. Antioxidant determinations by the use of a stable free radical. Nature 1958;181:1199–200. doi: 10.1038/1811199a0
   Web of Science ®Google Scholar
• Fagali N, Catala A. The effect of melatonin and structural analogues on the lipid peroxidation of triglycerides enriched in ω-3 polyunsaturated fatty acids. Life Sci 2007;81:299–305. doi: 10.1016/j.lfs.2007.05.013
   PubMed Web of Science ®Google Scholar
• Stoyanov S, Petkov I, Antonov L, Stoyanova T, Karagiannidis P, Aslanidis P. Thione–thiol tautomerism and stability of 2- and 4-mercaptopyridines and 2-mercaptopyrimidines. Can J Chem 1990;68(9):1482–9. doi: 10.1139/v90-227
   Web of Science ®Google Scholar
• Varynskyi BA, Scherback MA, Kaplaushenko AG, Yurchenko IA. The study of thione–thiol tautomerism of 4-amino-5-(4-nitrophenyl)-2,4-dihydro-3H-1,2,4-triazole-3-thione by HPLC–MS method. J Chem Pharm Res 2014;6(5):1342–50.
   Google Scholar
• Cheah IK, Halliwell B. Ergothioneine; antioxidant potential, physiological function and role in disease. Biochim Biophys Acta 2012;1822(5):784–93. doi: 10.1016/j.bbadis.2011.09.017
   PubMed Web of Science ®Google Scholar
• Trotta RJ, Sullivan SG, Stern A. Lipid peroxidation and haemoglobin degradation in red blood cells exposed to t-butyl hydroperoxide. The relative roles of haem- and glutathione-dependent decomposition of t-butyl hydroperoxide and membrane lipid hydroperoxides in lipid peroxidation and haemolysis. Biochem J 1983;212(3):759–72. doi: 10.1042/bj2120759
   PubMed Web of Science ®Google Scholar
• Thornalley PJ, Trotta RJ, Stern A. Free radical involvement in the oxidative phenomena induced by tert-butyl hydroperoxide in erythrocytes. Biochim Biophys Acta 1983;759(1–2):16–22. doi: 10.1016/0304-4165(83)90183-6
   PubMed Web of Science ®Google Scholar
• Munday R. Toxicity of thiols and disulphides: involvement of free-radical species. Free Radic Biol Med 1989;7:659–73. doi: 10.1016/0891-5849(89)90147-0
   PubMed Web of Science ®Google Scholar